HIV-associated Astrocyte Senescence as a Contributor to NeuroAIDS
HIV-associated Astrocyte Senescence as a Contributor to NeuroAIDS
批准号:
9195247
负责人:
Justin Cohen
金额:
$4.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-08 至 2018-12-07
关键词:
AffectAgeAge FactorsAge-YearsAgingAlzheimer&aposs DiseaseAmyloid beta-ProteinAnti-Retroviral AgentsAstrocytesBrainCell AgingCell physiologyCellsChronic DiseaseCoculture TechniquesComplex MixturesDNA DamageDataDevelopmentDrug CombinationsElderlyEnzyme-Linked Immunosorbent AssayFunctional disorderGrowthHIVHIV Envelope Protein gp120HIV-1HIV-associated neurocognitive disorderHighly Active Antiretroviral TherapyHomeostasisHumanIndividualInflammationInflammatoryInflammatory ResponseIntraventricularLamivudineLeadLongevityNerve DegenerationNeurogliaNeurologicNeurologic DysfunctionsNeuronal DysfunctionNeuronsNucleotidesOxidative StressOxidative Stress PathwayPathogenesisPathologyPathway interactionsPatientsPatternPharmaceutical PreparationsPhenotypePhysiologicalPopulationPredispositionPremature aging syndromeProliferatingProteinsPublic HealthRattusReportingReverse Transcriptase InhibitorsRiskRisk FactorsRitonavirRoleSignal PathwaySignal TransductionSorting - Cell MovementStimulusStressTelomere ShorteningTherapeuticTissuesToxic effectUnited StatesVertebral columnViral Envelope ProteinsViral reservoirVirusVirus Diseasesabacavirage relatedbeta-Galactosidasebiological adaptation to stressclinically relevantcomorbiditycomparativecytokineglial activationin vivoinhibitor/antagonistloss of functionneuroAIDSneurocognitive disorderneuroinflammationneurological pathologyneuron apoptosisneuropathologyneurotoxicityparacrinepatient populationprematureprogramsresponsesenescencetelomere
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Aging and age related co-morbidities are major risk factors for neurological pathologies. As the population
ages, this puts a major strain on public health. One population that is particularly at risk in the United States
are human immunodeficiency virus-1 (HIV-1) infected individuals as more than half of the population is now 50
years of age or older. Infected individuals show signs of premature aging and are prone to neurological
dysfunctions collectively known as HIV-associated neurocognitive disorders (HAND). The persistence of HAND
has been troubling since with the advent of highly active antiretroviral therapy (HAART), the virus is sufficiently
suppressed. Possible contributors to HAND therefore include the HAART drugs themselves as well as
reservoirs of the gp120 viral envelope protein hidden in the CNS. Since advancing age is critical for HAND, it is
likely that there is an interaction between aging and the factors that influence HAND pathology. We propose
that an age associated stress response in astrocytes known as cellular senescence in response to HAART
drugs and gp120 could be a contributor to HAND. We will examine the senescence-associated DNA damage
response, telomere damage and oxidative stress pathways activated in response to these stimuli. Since
senescence is accompanied by the secretion of pro-inflammatory proteins known as the senescence-
associated secretory phenotype, we will also determine the contribution of senescent astrocytes to
inflammation in response to these HIV-associated stimuli. We will also determine which signaling mechanisms
contribute to the secretions by using pharmacological inhibitors of major inflammatory centers. Neurons are
also sensitive to glial activation and their toxicity in response to activated glia are another possible HAND
contributor. We will examine if secretions from HIV-associated senescent astrocyte are able to cause
neurotoxicity and whether pharmacological inhibition of inflammation can mitigate this response. Our overall
objective is to determine the interaction between aging and HIV-associated factors as a contributor to HAND.
Since many age associated pathologies are associated with the accumulation of senescent cells, astrocyte
senescence in response to HAART drugs and gp120 could be a major contributor to HAND and Inhibition of
this response could be a public health boon as a potential therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring the role of hypoxia signaling and its inhibition as a therapy for Facioscapulohumeral muscular dystrophy
-
批准号:10463106
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2022
-
负责人:Justin Cohen
-
依托单位:
Exploring the role of hypoxia signaling and its inhibition as a therapy for Facioscapulohumeral muscular dystrophy
-
批准号:10599956
-
项目类别:
-
资助金额:$7.38万
-
财政年份:2022
-
负责人:Justin Cohen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: